CY1117637T1 - HUMAN ANTI-B7RP1 CONTROLLED ANTIBODIES - Google Patents
HUMAN ANTI-B7RP1 CONTROLLED ANTIBODIESInfo
- Publication number
- CY1117637T1 CY1117637T1 CY20161100402T CY161100402T CY1117637T1 CY 1117637 T1 CY1117637 T1 CY 1117637T1 CY 20161100402 T CY20161100402 T CY 20161100402T CY 161100402 T CY161100402 T CY 161100402T CY 1117637 T1 CY1117637 T1 CY 1117637T1
- Authority
- CY
- Cyprus
- Prior art keywords
- b7rp1
- antibodies
- function
- human anti
- human
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η εφεύρεση αυτή παρέχει αντισώματα που αλληλεπιδρούν με ανθρώπινη Β7 σχετική πρωτεΐνη-1 (B7RP1) ή συνδέονται προς ανθρώπινη Β7 σχετική πρωτεΐνη-1 (B7RP1) και αντισώματα που συνδέονται προς την λειτουργία της B7RP1 και με τον τρόπο αυτό εξουδετερώνουν την λειτουργία της B7RP1. Η εφεύρεση παρέχει επίσης φαρμακευτικές συνθέσεις των εν λόγω αντισωμάτων και μεθόδους για εξουδετέρωση λειτουργίας B7RP1 και ιδιαιτέρως για θεραπεία ανοσοδιαταραχών (π.χ., ακατάλληλης ανοσοαπόκρισης) με χορήγηση φαρμακευτικώς αποτελεσματικής ποσότητας των αντι-B7RP1 αντισωμάτων. Επίσης παρέχονται μέθοδοι για ανίχνευση ποσότητας B7RP1 σε ένα δείγμα χρησιμοποιώντας αντι-B7RP1 αντισώματα.This invention provides antibodies that interact with human B7 related protein-1 (B7RP1) or bind to human B7 related protein-1 (B7RP1) and antibodies that bind to the function of B7RP1 and thereby neutralize the function of B7RP1. The invention also provides pharmaceutical compositions of said antibodies and methods for neutralizing B7RP1 function, and in particular for the treatment of immune disorders (e.g., inappropriate immune response) by administering a pharmaceutically effective amount of anti-B7RP1 antibodies. Methods for detecting a quantity of B7RP1 in a sample using anti-B7RP1 antibodies are also provided.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70026505A | 2005-07-18 | 2005-07-18 | |
| EP06787719.1A EP1915398B1 (en) | 2005-07-18 | 2006-07-18 | Human anti-b7rp1 neutralizing antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1117637T1 true CY1117637T1 (en) | 2017-04-26 |
Family
ID=58606658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161100402T CY1117637T1 (en) | 2005-07-18 | 2016-05-12 | HUMAN ANTI-B7RP1 CONTROLLED ANTIBODIES |
Country Status (1)
| Country | Link |
|---|---|
| CY (1) | CY1117637T1 (en) |
-
2016
- 2016-05-12 CY CY20161100402T patent/CY1117637T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG164369A1 (en) | Human anti-b7rp1 neutralizing antibodies | |
| CY1113167T1 (en) | HUMAN ANTI-NGF CONTROLLED ANTIBODIES AS NGF pathway-selective inhibitors | |
| CY1119618T1 (en) | UNIONS AND COMPOSITIONS AS REGULATORY PARTS OF TLR ACTIVITY | |
| CY1121162T1 (en) | M-CSF-SPECIAL MONOCLONIC ANTIBODY AND ITS USE | |
| CY1120297T1 (en) | ANDROGEN RECEPTORS ADJUSTERS AND USES | |
| CY1120665T1 (en) | HUMANIZED ANTI-CXCR5 ANTIBODIES, DERIVATIVES OF THEM AND THEIR USES | |
| CY1116230T1 (en) | BINDING-NOTCH FACTORS AND COMPETITORS AND METHODS OF USE THEREOF | |
| CY1118943T1 (en) | ANTI-PD-L1 ANTIBODIES AND USE OF THESE TO ENHANCE T-CELL FUNCTIONING | |
| CY1118660T1 (en) | COMPOSITIONS AND METHODS FOR EYE DISORDER TREATMENT | |
| DE602005020474D1 (en) | Antibodies to phosphorylcholine conjugates | |
| CY1118377T1 (en) | SYK IMIDAZOPYRAZIN INHIBITIONS | |
| UA109633C2 (en) | HUMAN ANTIBODY AGAINST TISSUE FACTOR | |
| CY1113640T1 (en) | METHODS FOR TREATMENT OF Rheumatoid Arthritis | |
| EA200800952A1 (en) | CONJUGATES ANTIBODY-DRUG AND METHODS OF APPLICATION | |
| CY1112751T1 (en) | METHOD OF FORMING THE PROTEIN COGNITION WITH GPR119 RECEPTORS AND SELECTED COMPOUNDS | |
| CY1115871T1 (en) | METHODS FOR TREATMENT OF URINARY ARTHRITIS | |
| CY1112739T1 (en) | ANTI-CD79B ANTIBODIES AND IMMUNIZATIONS AND METHODS OF USE | |
| ECSP088804A (en) | ANTAGONISTS OF THE AMIDA PIRIDIL OF THE TYPE T CALCIUM CHANNELS | |
| CU24644B1 (en) | ANTIBODY-DRUG CONJUGATES FOR ABLATION OF HEMATOPOIETIC STEM CELLS | |
| CR10099A (en) | IMMUNOGLOBULINS DIRECTED AGAINST NOGO | |
| ATE511845T1 (en) | USE OF ISOTHICYANATE DERVIATES AS MYELOMA-FIGHTING ACTIVES | |
| ATE476193T1 (en) | IMMUNO-STIMULATORY PROCEDURE | |
| EA201070636A1 (en) | INHIBITION OF THE PROTECTOR PROTEIN, STIMULATING MACROPHAGE (RON), AND METHODS OF ITS TREATMENT | |
| CY1110190T1 (en) | Piperazinyl derivative useful in the treatment of diseases mediated by the GPR38 receptor | |
| CY1116802T1 (en) | Heterocyclic compounds |